1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
Avanos Medical, Inc.

Avanos Medical, Inc.

AVNS
Avanos Medical, Inc.US flagNew York Stock Exchange
24.96
USD
-0.02
- -
1.17BMarket Cap

Total Valuation

Avanos Medical, Inc. carries a market capitalization of 1.17B, placing it among publicly traded companies globally. Its enterprise value stands at 722.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.17B
Enterprise Value722.86M

Share Statistics

Avanos Medical, Inc. currently has 46.67M shares outstanding.

Shares Outstanding46.67M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 0.91, and the price-to-book ratio stands at -0.84.

PE RatioN/A
PS Ratio0.91
PB Ratio-0.84
P/TBV Ratio2.38
P/FCF Ratio17.81
P/OCF Ratio17.71

Enterprise Valuation

On an enterprise value basis, Avanos Medical, Inc. trades at an EV/EBITDA multiple of 13.51 and an EV/FCF ratio of 16.23. The EV/Sales ratio of 1.01 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 51.63 provides insight into valuation relative to core operating earnings.

EV / Sales1.01
EV / EBITDA13.51
EV / EBIT51.63
EV / FCF16.23

Financial Position

Avanos Medical, Inc. maintains a current ratio of 2.48, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 17.70, indicating elevated leverage, while an interest coverage ratio of 7.43 demonstrates adequate ability to service its debt obligations.

Current Ratio2.48
Quick Ratio1.29
Debt / Equity17.70
Debt / EBITDA2.59
Interest Coverage7.43

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-6.90
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)1.53
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.56

Taxes

Over the trailing twelve months, Avanos Medical, Inc. has paid 6.10M in income taxes, reflecting an effective tax rate of 241.23.

Income Tax6.10M
Effective Tax Rate241.23

Stock Price Statistics

Avanos Medical, Inc.'s stock has gained approximately 104.08831% over the past 52 weeks. The 50-day moving average sits at 23.27, while the 200-day moving average is 15.11.

Beta (5Y)N/A
52-Week Price Change104.08831%
50-Day Moving Average23.27
200-Day Moving Average15.11
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Avanos Medical, Inc. generated 715.90M in revenue and converted that into -74.40M in net income, yielding earnings per share of -1.59. EBITDA reached 53.50M, while operating income came in at 14.00M.

Revenue715.90M
Gross Profit358.30M
Operating Income14.00M
Pretax Income-68.30M
Net Income-74.40M
EBITDA53.50M
EBIT14.00M
Earnings Per Share (EPS)-1.59

Balance Sheet

Avanos Medical, Inc. holds 65.60M in cash and equivalents against 138.40M in total debt, resulting in a net debt position of 32.60M. Total book value stands at -774.80M, with working capital of 193.80M providing operational flexibility.

Cash & Cash Equivalents65.60M
Total Debt138.40M
Net Debt32.60M
Equity (Book Value)-774.80M
Book Value Per Share-16.70
Working Capital193.80M

Cash Flow

Avanos Medical, Inc. produced 36.70M in operating cash flow over the past twelve months.

Operating Cash Flow36.70M
Capital ExpendituresN/A
Free Cash Flow36.70M
FCF Per Share0.79

Margins

Avanos Medical, Inc. operates with a gross margin of 50.05, reflecting its pricing power and cost economics. The operating margin of 1.96 and net profit margin of -10.39 provide insight into operational efficiency.

Gross Margin50.05
Operating Margin1.96
Pretax Margin-9.54
Profit Margin-10.39
EBITDA Margin7.47

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield1.71
FCF Yield5.62

Scores

Avanos Medical, Inc. posts an Altman Z-Score of 1.29, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score1.29